期刊
AMERICAN JOURNAL OF KIDNEY DISEASES
卷 72, 期 4, 页码 560-568出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ajkd.2018.04.007
关键词
-
资金
- National Institute of Diabetes and Digestive and Kidney Diseases [1K23DK101693-01]
- endowed Gordon A. Cain Chair in Nephrology at Baylor College of Medicine
Rapid growth in electronic communications and digitalization, combined with advances in data management, analysis, and storage, have led to an era of Big Data. The Social Security Amendments of 1972 turned end-stage renal disease (ESRD) care into a single-payer system for most patients requiring dialysis in the United States. As a result, there are few areas of medicine that have been as influenced by Big Data as dialysis care, for which Medicare's large administrative data sets have had a central role in the evaluation and development of public policy for several decades. In the 1970/1980s, Medicare data helped identify concerning trends in costs, access to dialysis care, and quality of care delivered. As the research community and policymakers made Medicare's administrative data increasingly accessible for investigation, analyses of Medicare claims have had a large role in facilitating policy synthesis and refinement. Efforts to address the skyrocketing cost of injectable drugs in the 1990s and 2000s exemplify this expanded role of Big Data. Although there are opportunities for large government and nongovernmental administrative data sets to continue serving a critical role in the evaluation and development of ESRD policies, it is important to understand challenges and limitations associated with their use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据